These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Vanderschueren D, van Herck E, Nijs J, Ederveen AG, De Coster R, Bouillon R. Endocrinology; 1997 Jun; 138(6):2301-7. PubMed ID: 9165015 [Abstract] [Full Text] [Related]
3. Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. Vanderschueren D, Boonen S, Ederveen AG, de Coster R, Van Herck E, Moermans K, Vandenput L, Verstuyf A, Bouillon R. Bone; 2000 Nov; 27(5):611-7. PubMed ID: 11062346 [Abstract] [Full Text] [Related]
6. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Vanderschueren D, Van Herck E, Suiker AM, Visser WJ, Schot LP, Bouillon R. Endocrinology; 1992 May; 130(5):2906-16. PubMed ID: 1572302 [Abstract] [Full Text] [Related]
7. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944 [Abstract] [Full Text] [Related]
8. Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats. Iwamoto J, Takeda T, Katsumata T, Tanaka T, Ichimura S, Toyama Y. Bone; 2002 Feb; 30(2):360-7. PubMed ID: 11856643 [Abstract] [Full Text] [Related]
12. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys. Wickman S, Kajantie E, Dunkel L. J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670 [Abstract] [Full Text] [Related]
13. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2. Otomo H, Sakai A, Ikeda S, Tanaka S, Ito M, Phipps RJ, Nakamura T. J Bone Miner Metab; 2004 Aug; 22(5):404-14. PubMed ID: 15316861 [Abstract] [Full Text] [Related]
17. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats. Sato M, McClintock C, Kim J, Turner CH, Bryant HU, Magee D, Slemenda CW. J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401 [Abstract] [Full Text] [Related]
18. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats. Armamento-Villareal R, Sheikh S, Nawaz A, Napoli N, Mueller C, Halstead LR, Brodt MD, Silva MJ, Galbiati E, Caruso PL, Civelli M, Civitelli R. J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271 [Abstract] [Full Text] [Related]
19. Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. Erben RG, Eberle J, Stahr K, Goldberg M. J Bone Miner Res; 2000 Jun; 15(6):1085-98. PubMed ID: 10841177 [Abstract] [Full Text] [Related]
20. Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats. Goss PE, Qi S, Cheung AM, Hu H, Mendes M, Pritzker KP. Clin Cancer Res; 2004 Sep 01; 10(17):5717-23. PubMed ID: 15355898 [Abstract] [Full Text] [Related] Page: [Next] [New Search]